Pharmacielo Stock Market Capitalization
PCLO Stock | CAD 0.09 0.01 5.88% |
Pharmacielo fundamentals help investors to digest information that contributes to Pharmacielo's financial success or failures. It also enables traders to predict the movement of Pharmacielo Stock. The fundamental analysis module provides a way to measure Pharmacielo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmacielo stock.
Last Reported | Projected for Next Year | ||
Market Cap | 28.8 M | 27.4 M |
Pharmacielo | Market Capitalization |
Pharmacielo Company Market Capitalization Analysis
Pharmacielo's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Pharmacielo Market Capitalization | 14.43 M |
Most of Pharmacielo's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmacielo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pharmacielo Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Pharmacielo is extremely important. It helps to project a fair market value of Pharmacielo Stock properly, considering its historical fundamentals such as Market Capitalization. Since Pharmacielo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharmacielo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharmacielo's interrelated accounts and indicators.
Click cells to compare fundamentals
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition |
Pharmacielo Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of Pharmacielo is about 14.43 M. This is 99.89% lower than that of the Pharmaceuticals sector and 99.71% lower than that of the Health Care industry. The market capitalization for all Canada stocks is 99.92% higher than that of the company.
Pharmacielo is regarded second in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 41.25 Million. Pharmacielo totals roughly 14.43 Million in market capitalization claiming about 35% of equities under Health Care industry.Pharmacielo Fundamentals
Return On Equity | -30.13 | ||||
Return On Asset | -0.2 | ||||
Operating Margin | (2.12) % | ||||
Current Valuation | 34.53 M | ||||
Shares Outstanding | 169.74 M | ||||
Shares Owned By Insiders | 8.43 % | ||||
Shares Owned By Institutions | 4.58 % | ||||
Number Of Shares Shorted | 28.63 K | ||||
Price To Book | 9.48 X | ||||
Price To Sales | 8.91 X | ||||
Revenue | 1.54 M | ||||
Gross Profit | (4.17 M) | ||||
EBITDA | (7.56 M) | ||||
Net Income | (16.3 M) | ||||
Cash And Equivalents | 33.46 M | ||||
Cash Per Share | 0.34 X | ||||
Total Debt | 15.71 M | ||||
Debt To Equity | 2.70 % | ||||
Current Ratio | 7.36 X | ||||
Book Value Per Share | (0.03) X | ||||
Cash Flow From Operations | (5.15 M) | ||||
Short Ratio | 0.11 X | ||||
Earnings Per Share | (0.08) X | ||||
Target Price | 2.5 | ||||
Beta | 2.39 | ||||
Market Capitalization | 14.43 M | ||||
Total Asset | 22.29 M | ||||
Retained Earnings | (198.71 M) | ||||
Working Capital | (18.09 M) | ||||
Net Asset | 22.29 M |
About Pharmacielo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmacielo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmacielo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmacielo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharmacielo Stock Analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.